Risto the Great
Senior Member
Great news, I was getting nervous but no need to stress now. Vaccines for 5-11 year olds are now approved in Australia. They will get a smaller dosage but more shots. I am so relieved! We already know the TGA is industry funded, meaning Pfizer simply needs to pay enough to be approved, but I thought ATAGI was going to reject the jabs based on the mounting evidence of myocarditis and other heart related illnesses (among other deadly side effects) in children.
The good news is that I wasn't disappointed in my beliefs. The bad news is that children will die for ZERO reason other than to make the likes of Pfizer richer. Oh, and digital ID tracking. We just have to look on the bright side I guess.
It's a funny old world when we can guarantee more children will die from a vaccine than from the purported illness that the vaccine was meant to protect them from. When I say funny, I mean absolutely evil.
There is probably a reason why people can't seem to be objective about these issues. It relates to a medical procedure called selling your arse to the highest bidder. Following are some conflicts of interest of people on the boards who are making these decisions. These are the people who may end up being charged with crimes against humanity (in Australia) in years to come:
https://pennybutler.com/conflicts-australia-covid/
Dr Katie ATTWELL
Member of Immunisation Coalition (01) , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (02).
Part of a team conducting an evaluation of the “I Immunise” campaign, funded through an unrestricted grant from vaccine manufacturer Sanofi-Pasteur (03)
Prof Kristine MACARTNEY
$65,330,038 in government grants covering 2020-2023.
She is also a member of the Advisory Committee on vaccines (ACV) of the Therapeutic Goods Administration (TGA). Prof Kristine Macartney has also acted as an expert consultant to the World Health Organisation (WHO).
She was also one of the contributing authors of a peer-reviewed paper entitled “Constructing an ethical framework for priority allocation of pandemic vaccines.” Read paper here: https://doi.org/10.1016/j.vaccine.2020.12.053
Prof Kristine Macartney was chosen to represent the government in the NSW Supreme Court hearings.
Director of National Centre for Immunisation Reseasrch & Surveillance (NCIRS) (04)
Presentation at “International Vaccine conference”, where travel was sponsored (05)
Ex-officio Member of ATAGI (06)
In 2018, member of ATAGI’s “Influenza Working Party” which prepares advice for ATAGI (07)
Member of ATAGI’s “Pertussis Working Party” which prepare advice on the epidemiology of pertussis and potential vaccination strategies in Australia (08)
Member of ATAGI’s “HPV working Party” which prepare advice on the epidemiology of HPV and potential vaccination strategies in Australia (09)
Member of ATAGI’s COVID-19 Working Group (10) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Prof Ian BARR
Member of Immunisation Coalition (11), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (12)
Deputy Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Doherty Institute, where he has had over 35 years’ experience in biological research and development in academic institutions and at CSL on various topics such as vaccine development (13)
From 2015 to 2016 and in 2007, was on the Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines (14)
Dr Tony BARTONE
Former President of the Australian Medical Association (15) (resigned late 2020 after 2 years).
Member of Immunisation Coalition (16), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (17).
A/Prof Christopher BLYTH
Investigator on a pneumonia/meningitis study in Papua New Guinea. Grant received by employer (The University of Western Australia) from Pfizer (18)
Co-Director of Wesfarmers Centre for Vaccines and Infectious Diseases; Telethon Kids (19), which is partnered with Johnson & Johnson, Roche, Pfizer, Novartis, GSK and Sanofi (20)
Co-Chair of ATAGI’s COVID-19 Working Group (21) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Co-Chair of Australian Technical Advisory Group on Immunisation (ATAGI). (22)
Member of COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Board (23)
Prof Robert BOOY
Medical Advisor of Meningococcal Australia (24), which has received funds from vaccine manufacturers GSK and Pfizer (25)
Was Head of Clinical Research at the National Centre for Immunisation Research & Surveillance 2005 to 2019 (26)
Previously Chair, currently Director and Scientific Advisory Member of the Immunisation Coalition (27) , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (28).
In 2009, Robert Booy was a co-author of an “Influenza Vaccine trial” which was funded by CSL (29)
He received funding from CSL, Roche, Sanofi Pasteur, GSK and Pfizer to conduct research or attend and present at scientific meetings (30)
Member of Friends of Science in Medicine (31), which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 (32)
A/Prof Julia BROTHERTON
Co-Author of the Department of Health’s report “Planning for human papillomavirus vaccines in Australia”. This is the report of a meeting convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 12 December 2003, bringing together representatives from eight Australian research groups involved in HPV research, and vaccine manufacturers with HPV vaccine candidates. The meeting was supported by vaccine manufacturers CSL Pharmaceuticals and Glaxo SmithKline (33)
Prof Allen CHENG
Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health (34), which has received payments from vaccine manufactureres Biocryst, George Clinical, Gilead, GSK and Merck (35), and has an appointment in the School of Public Health and Preventive Medicine at Monash University (36).
Co-Chair of ATAGI. (37)
Member of the COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Group (38)
Co-Chair of ATAGI’s COVID-19 Working Group (39) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Deputy Chief Health Officer of Victoria (40) and influential on coronavirus policy.
Therapeutic Goods Administration (TGA) Advisory Committee on infectious diseases and biostatistics (41)
Site Investigator for a number of infectious disease studies via Alfred Health, which has received payments from vaccine manufacturers Biocryst, George Clinical, Gilead, GSK and Merck (42)
Chief Investigator for influenza surveillance (FluCAN Surveillance System) (43)
In 2018 Chair of the Influenza Working Party which prepares advice for ATAGI (44)
His team has recently received $1.7M from federal governments National Health & Medical Research Council (NHMRC), Refer to NHMRC section below for COI, towards research into how influenza virus infection results in severe illness and death in Australia (45)
Peter COSTELLO
Chairman of the Board of Guardians of the Future Fund (46), an Australian government investment fund, with over 2 billion dollars worth of shares in pharmaceutical and vaccine manufacturers i.e. CSL, Johnson and Johnson, Pfizer, Novartis and Merck (47). The Future Funds investment in pharmaceutical and vaccine manufacturers has doubled from $1 billion to $2 billion during the coronavirus situation.
Non-Executive Chairman of Nine Entertainment Co. (48)
Nine Entertainment own newspapers “the Sydney Morning Herald” and “The Sun Herald” (49), who were/are instrumental in “anti-vax” labelling (50).
A/Prof Nigel CRAWFORD
Currently Director of Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC) at Murdoch Children’s Research Institute (51), which has received funding from Vaccination and Immunisation Research Group from Novartis Vaccines, GSK and Sanofi (52) & (53)
In 2014 was appointed to ATAGI (54)
Member of ATAGI’s COVID-19 Working Group (55) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Previously Director of The Influenza Specialist Group (56), which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi (57).
A/Prof Margie DANCHIN
Member of Immunisation Coalition (58), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google (59).
Group Leader of Vaccine Updake at Murdoch Children’s Research Institute (MCRI) (60)
She is also promoting COVID-19 vaccination amongst elderly and children (61).
Laureate Prof Peter DOHERTY
The Doherty Institute for Infection & Immunity is named in honour of Patron, Laureate Professor Peter Doherty, winner of the 1996 Nobel Prize (62) , where Peter Doherty is still active in science and involved in large, grant-funded programs at both institutions, he commutes between St Jude Children’s Research Hospital in Memphis and the Doherty Institute where he now spends most of his time (63).
The Peter Doherty Institute is also in collaboration with Vaccine and Immunisation Research Group/Murdoch Children’s Research Institute (64) which has received funding from vaccine manufacturers GSK, Janssen, Merck, Novavax, Sanofi and Sequiris (65).
The Peter Doherty Institute have released their work on COVID-19 modelling to the general public. These models have been utilised by the Commonwealth Government in the public health response to COVID-19 (66).
Peter Doherty is a member of Friends of Science in Medicine (67), which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 (68)
A/Prof Katie FLANAGAN
Is affiliated to Monash University (69).
In the last 10 years has been involved in research projects awarded in excess of AU$30 million, includes grants from NHMRC and Bill and Melinda Gates Foundation (70).
Former member of Influenza Vaccine Advisory Board, travel paid for by vaccine manufacturers Sanofi and Seqirus (71)
Member of ATAGI’s COVID-19 Working Group (72) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Presenter at a number of conferences in clinical infectious diseases sponsored by vaccine manufacturer Pfizer (73)
Former member of a number of vaccine advisory boards for the influenza vaccine (74)
the list goes on ....
The good news is that I wasn't disappointed in my beliefs. The bad news is that children will die for ZERO reason other than to make the likes of Pfizer richer. Oh, and digital ID tracking. We just have to look on the bright side I guess.
It's a funny old world when we can guarantee more children will die from a vaccine than from the purported illness that the vaccine was meant to protect them from. When I say funny, I mean absolutely evil.
There is probably a reason why people can't seem to be objective about these issues. It relates to a medical procedure called selling your arse to the highest bidder. Following are some conflicts of interest of people on the boards who are making these decisions. These are the people who may end up being charged with crimes against humanity (in Australia) in years to come:
https://pennybutler.com/conflicts-australia-covid/
Dr Katie ATTWELL
Member of Immunisation Coalition (01) , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (02).
Part of a team conducting an evaluation of the “I Immunise” campaign, funded through an unrestricted grant from vaccine manufacturer Sanofi-Pasteur (03)
Prof Kristine MACARTNEY
$65,330,038 in government grants covering 2020-2023.
She is also a member of the Advisory Committee on vaccines (ACV) of the Therapeutic Goods Administration (TGA). Prof Kristine Macartney has also acted as an expert consultant to the World Health Organisation (WHO).
She was also one of the contributing authors of a peer-reviewed paper entitled “Constructing an ethical framework for priority allocation of pandemic vaccines.” Read paper here: https://doi.org/10.1016/j.vaccine.2020.12.053
Prof Kristine Macartney was chosen to represent the government in the NSW Supreme Court hearings.
Director of National Centre for Immunisation Reseasrch & Surveillance (NCIRS) (04)
Presentation at “International Vaccine conference”, where travel was sponsored (05)
Ex-officio Member of ATAGI (06)
In 2018, member of ATAGI’s “Influenza Working Party” which prepares advice for ATAGI (07)
Member of ATAGI’s “Pertussis Working Party” which prepare advice on the epidemiology of pertussis and potential vaccination strategies in Australia (08)
Member of ATAGI’s “HPV working Party” which prepare advice on the epidemiology of HPV and potential vaccination strategies in Australia (09)
Member of ATAGI’s COVID-19 Working Group (10) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Prof Ian BARR
Member of Immunisation Coalition (11), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (12)
Deputy Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Doherty Institute, where he has had over 35 years’ experience in biological research and development in academic institutions and at CSL on various topics such as vaccine development (13)
From 2015 to 2016 and in 2007, was on the Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines (14)
Dr Tony BARTONE
Former President of the Australian Medical Association (15) (resigned late 2020 after 2 years).
Member of Immunisation Coalition (16), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (17).
A/Prof Christopher BLYTH
Investigator on a pneumonia/meningitis study in Papua New Guinea. Grant received by employer (The University of Western Australia) from Pfizer (18)
Co-Director of Wesfarmers Centre for Vaccines and Infectious Diseases; Telethon Kids (19), which is partnered with Johnson & Johnson, Roche, Pfizer, Novartis, GSK and Sanofi (20)
Co-Chair of ATAGI’s COVID-19 Working Group (21) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Co-Chair of Australian Technical Advisory Group on Immunisation (ATAGI). (22)
Member of COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Board (23)
Prof Robert BOOY
Medical Advisor of Meningococcal Australia (24), which has received funds from vaccine manufacturers GSK and Pfizer (25)
Was Head of Clinical Research at the National Centre for Immunisation Research & Surveillance 2005 to 2019 (26)
Previously Chair, currently Director and Scientific Advisory Member of the Immunisation Coalition (27) , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (28).
In 2009, Robert Booy was a co-author of an “Influenza Vaccine trial” which was funded by CSL (29)
He received funding from CSL, Roche, Sanofi Pasteur, GSK and Pfizer to conduct research or attend and present at scientific meetings (30)
Member of Friends of Science in Medicine (31), which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 (32)
A/Prof Julia BROTHERTON
Co-Author of the Department of Health’s report “Planning for human papillomavirus vaccines in Australia”. This is the report of a meeting convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 12 December 2003, bringing together representatives from eight Australian research groups involved in HPV research, and vaccine manufacturers with HPV vaccine candidates. The meeting was supported by vaccine manufacturers CSL Pharmaceuticals and Glaxo SmithKline (33)
Prof Allen CHENG
Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health (34), which has received payments from vaccine manufactureres Biocryst, George Clinical, Gilead, GSK and Merck (35), and has an appointment in the School of Public Health and Preventive Medicine at Monash University (36).
Co-Chair of ATAGI. (37)
Member of the COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Group (38)
Co-Chair of ATAGI’s COVID-19 Working Group (39) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Deputy Chief Health Officer of Victoria (40) and influential on coronavirus policy.
Therapeutic Goods Administration (TGA) Advisory Committee on infectious diseases and biostatistics (41)
Site Investigator for a number of infectious disease studies via Alfred Health, which has received payments from vaccine manufacturers Biocryst, George Clinical, Gilead, GSK and Merck (42)
Chief Investigator for influenza surveillance (FluCAN Surveillance System) (43)
In 2018 Chair of the Influenza Working Party which prepares advice for ATAGI (44)
His team has recently received $1.7M from federal governments National Health & Medical Research Council (NHMRC), Refer to NHMRC section below for COI, towards research into how influenza virus infection results in severe illness and death in Australia (45)
Peter COSTELLO
Chairman of the Board of Guardians of the Future Fund (46), an Australian government investment fund, with over 2 billion dollars worth of shares in pharmaceutical and vaccine manufacturers i.e. CSL, Johnson and Johnson, Pfizer, Novartis and Merck (47). The Future Funds investment in pharmaceutical and vaccine manufacturers has doubled from $1 billion to $2 billion during the coronavirus situation.
Non-Executive Chairman of Nine Entertainment Co. (48)
Nine Entertainment own newspapers “the Sydney Morning Herald” and “The Sun Herald” (49), who were/are instrumental in “anti-vax” labelling (50).
A/Prof Nigel CRAWFORD
Currently Director of Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC) at Murdoch Children’s Research Institute (51), which has received funding from Vaccination and Immunisation Research Group from Novartis Vaccines, GSK and Sanofi (52) & (53)
In 2014 was appointed to ATAGI (54)
Member of ATAGI’s COVID-19 Working Group (55) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Previously Director of The Influenza Specialist Group (56), which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi (57).
A/Prof Margie DANCHIN
Member of Immunisation Coalition (58), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google (59).
Group Leader of Vaccine Updake at Murdoch Children’s Research Institute (MCRI) (60)
She is also promoting COVID-19 vaccination amongst elderly and children (61).
Laureate Prof Peter DOHERTY
The Doherty Institute for Infection & Immunity is named in honour of Patron, Laureate Professor Peter Doherty, winner of the 1996 Nobel Prize (62) , where Peter Doherty is still active in science and involved in large, grant-funded programs at both institutions, he commutes between St Jude Children’s Research Hospital in Memphis and the Doherty Institute where he now spends most of his time (63).
The Peter Doherty Institute is also in collaboration with Vaccine and Immunisation Research Group/Murdoch Children’s Research Institute (64) which has received funding from vaccine manufacturers GSK, Janssen, Merck, Novavax, Sanofi and Sequiris (65).
The Peter Doherty Institute have released their work on COVID-19 modelling to the general public. These models have been utilised by the Commonwealth Government in the public health response to COVID-19 (66).
Peter Doherty is a member of Friends of Science in Medicine (67), which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 (68)
A/Prof Katie FLANAGAN
Is affiliated to Monash University (69).
In the last 10 years has been involved in research projects awarded in excess of AU$30 million, includes grants from NHMRC and Bill and Melinda Gates Foundation (70).
Former member of Influenza Vaccine Advisory Board, travel paid for by vaccine manufacturers Sanofi and Seqirus (71)
Member of ATAGI’s COVID-19 Working Group (72) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Presenter at a number of conferences in clinical infectious diseases sponsored by vaccine manufacturer Pfizer (73)
Former member of a number of vaccine advisory boards for the influenza vaccine (74)
the list goes on ....